17 March 2026
17 March 2026
The court ruling reverses several changes by the CDC’s vaccine panel to childhood immunisation recommendations.
A slow NHS rollout has so far limited wide-ranging eligibility, meaning many patients have turned to private healthcare.
Ilumya has secured marketing authorisations from more than 55 health authorities worldwide.
Sentynl will acquire full rights to Progerinin for HGPS, provided certain milestones are achieved.
Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA in this expanded, high-risk adult population.
While the FDA maintains the legal right to make prescription meds OTC, legal expert Heidi Gertner believes that this wider shift depends on pharma’s engagement.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
